These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 9552059

  • 1. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
    Surtees R, Clelland J, Hann I.
    J Clin Oncol; 1998 Apr; 16(4):1505-11. PubMed ID: 9552059
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
    Hill FG, Richards S, Gibson B, Hann I, Lilleyman J, Kinsey S, Mitchell C, Harrison CJ, Eden OB, UK Medical Research Council Working Party on Childhood Leukaemia.
    Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406
    [Abstract] [Full Text] [Related]

  • 3. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Jan; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 4. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B.
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L, Kovala T, Tolonen U, Lanning M.
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC.
    Cancer; 1998 Jan 01; 82(1):208-18. PubMed ID: 9428499
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood.
    Surtees R, Clelland J, Heales S.
    Leuk Res; 1998 Aug 01; 22(8):751-4. PubMed ID: 9680103
    [Abstract] [Full Text] [Related]

  • 13. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J, Valík D, Bajciová V, Kadlecová V, Gregorová V, Mendelová D.
    Neoplasma; 2005 Aug 01; 52(6):456-63. PubMed ID: 16284689
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-dose methotrexate in childhood all.
    Moe PJ, Holen A.
    Pediatr Hematol Oncol; 2000 Dec 01; 17(8):615-22. PubMed ID: 11127393
    [Abstract] [Full Text] [Related]

  • 16. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.
    J Clin Oncol; 2006 Aug 20; 24(24):3858-64. PubMed ID: 16921038
    [Abstract] [Full Text] [Related]

  • 17. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P, Oviedo I, Campbell M, Tordecilla J.
    Pediatr Blood Cancer; 2004 Jul 20; 43(1):17-22. PubMed ID: 15170885
    [Abstract] [Full Text] [Related]

  • 18. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D, Yldrmak Y, Kenangil G, Kandraloğlu N, Forta H, Celik M.
    J Pediatr Hematol Oncol; 2009 Jan 20; 31(1):57-8. PubMed ID: 19125090
    [Abstract] [Full Text] [Related]

  • 19. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N, Griffioen PH, den Hoed MAH, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.
    PLoS One; 2018 Jan 20; 13(7):e0199574. PubMed ID: 29985926
    [Abstract] [Full Text] [Related]

  • 20. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN, Wolff L, Trigg ME.
    J Clin Oncol; 1998 Mar 20; 16(3):920-30. PubMed ID: 9508174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.